RARE-51. RITUXIMAB, METHOTREXATE, BCNU, ETOPOSIDE, AND PREDNISONE (RMBVP) FOR THE TREATMENT OF RELAPSED/RECURRENT PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: A RETROSPECTIVE SINGLE CENTER STUDY

BACKGROUND: Primary Central Nervous System Lymphoma (PCNSL) is an aggressive rare non-Hodgkin lymphoma. Prognosis is particularly poor for relapsed/recurrent (R/R) patients with no established treatment modality. Methotrexate/BCNU/Teniposide/Prednisone with or without rituximab has efficacy in newly...

Full description

Saved in:
Bibliographic Details
Published in:Neuro Oncol
Main Authors: Reiss, Samantha, Yerram, Prakirthi, Modelevsky, Lisa, Grommes, Christian
Format: Artigo
Language:Inglês
Published: Oxford University Press 2019
Subjects:
Rare Tumors
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6846926/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.1194
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items